Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Medicines Co (MDCO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q1 | 0 | 0.00 | Sell 100.00% | 0.10 | SEC | ||
| 2019 Q4 | 409,112 | 0.10 | Reduce 46.45% | 0.05 | $84.94 | $34,750,000 | SEC |
| 2019 Q3 | 764,012 | 0.11 | Add 59.71% | 0.04 | $50.00 | $38,201,000 | SEC |
| 2019 Q2 | 478,373 | 0.05 | Reduce 2.94% | <0.01 | $36.47 | $17,446,000 | SEC |
| 2019 Q1 | 492,873 | 0.04 | Add 10.25% | <0.01 | $27.95 | $13,776,000 | SEC |
| 2018 Q4 | 447,035 | 0.02 | Add 26.69% | <0.01 | $19.14 | $8,556,000 | SEC |
| 2018 Q3 | 352,868 | 0.03 | $29.91 | $10,554,000 | SEC | ||
| 2018 Q2 | 352,868 | 0.03 | Reduce 24.25% | <0.01 | $36.70 | $12,950,000 | SEC |
| 2018 Q1 | 465,863 | 0.04 | $32.94 | $15,346,000 | SEC | ||
| 2017 Q4 | 465,863 | 0.03 | $27.34 | $12,737,000 | SEC | ||
| 2017 Q3 | 465,863 | 0.04 | Reduce 40.96% | 0.03 | $37.04 | $17,256,000 | SEC |
| 2017 Q2 | 789,014 | 0.07 | Reduce 20.37% | 0.02 | $38.01 | $29,990,000 | SEC |
| 2017 Q1 | 990,899 | 0.12 | Reduce 6.08% | <0.01 | $48.90 | $48,455,000 | SEC |
| 2016 Q4 | 1,055,029 | 0.09 | Add 3.37% | <0.01 | $33.94 | $35,808,000 | SEC |
| 2016 Q3 | 1,020,629 | 0.10 | Add 83.86% | 0.05 | $37.74 | $38,519,000 | SEC |
| 2016 Q2 | 555,099 | 0.05 | Buy | 0.05 | $33.63 | $18,668,000 | SEC |